Abstract
The pharmacokinetics of IFN’s α, β and γ are reviewed pointing out their short half-lives, their distribution and major catabolic sites. After several years of IFN clinical trials based on empirical approaches it is now clear that IFNs are pharmacodynamically neither comparable to antibiotics nor to cytotoxic agents and it may be useful to test unconventional routes of administration which may improve their therapeutic index.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bocci, V. Trends Biochem. Sci. 8: 432–434, 1983
Bocci, V., Pessina, G.P., Pacini, A., Paulesu, L., Muscettola, M., Naldani, A. and Maioli, E. In: The Interferon System (Eds. F. Dianzani and G.B. Rossi), Serono Symposia Vol. 24, Raven Press, New Yor, 1985, pp. 129–135.
Bocci, V. In: Interferon. Vol. 4: In Vivo and Clinical Studies (Eds. N.B. Finter and R.K. Oldham), Elsevier Science Publishers B.V., Amsterdam, 1985, pp. 47–72.
Warren, B.A. In: Tumour Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental Tumours (Ed. H.I. Peterson), CRC Press Inc., Boca Raton, Florida, 1979, pp. 20–35.
Bocci, V., Pessina, G.P., Pacini, A., Paulesu, L., Muscettola, M., Naldini, A. and Lunghetti, G. Gen. Pharmac. 16: 277–279, 1985.
Greenblatt, D.J. and Koch-Weser, J. New England J. Med. 293: 702–705, 1975.
Emodi, G., Just, M., Hernandez, R. and Hirt, H.R. J. Natl. Cancer Inst. 54: 1045–1049, 1975.
Bornemann, L.D., Spiegel, H.E., Dziewanowska, Z.E., Krown,, S.E. and Colburn, W.A. Eur. J. Clin. Pharmacol. 28: 469–471, 1985.
Treuner, J., Dannecker, G., Joester, K.-E., Hettinger, A. and Niethammer, D. J. Interferon Res. 1: 373–380, 1981.
Gutterman, J.U., Rosenblum, M.G., Rios, A., Fritsche, H.A. and Quesada, J.R. Cancer Res. 44: 4164–4171, 1984.
Hawkins, M., Horning, S., Konrad,M., Anderson, S., Sielaff, K. Rosno, S., Schiesel, J., Davis, T., DeMets, D., Merigan, T. and Borden, E. Cancer Res. 45: 5914–5920, 1985.
Kurzrock, R., Rosenblum, M.G., Sherwin, S.A., Rios, A., Talpaz, M., Quesada, J.R. and Gutterman, J.U. Cancer Res. 45: 2866–2872, 1985.
Gutterman, J.U., Fine, S., Quesada, J., Horning, S.J., Levine, J.F., Alexanian, R., Bernhardt, L., Kramer, M., Spiegel, H., Colburn, W., Trown, P., Merigan, T. and Dziewanowski, Z. Ann. Int. Med. 96: 549–556, 1982.
Quesada, J.R., Gutterman, J.U. and Hersh, E.M. J. Interferon Res. 2: 593–599, 1982.
Schonfeld, A., Nitke, S., Schattner, A., Wallach, D., Crespi, M., Hahn, T., Levavi, H., Yarden, O., Shoham, J., Doerner, T. Revel, M. The Lancet i: 1038–1042, 1984.
Lucero, M.A., Magdelenat, H., Fridman, W.H., Pouillart, P., Billardon, C, Billiau, A., Cantell, K. and Falcoff, E. Eur. J. Cancer Clin. Oncol. 18: 243–251, 1982.
Pouillart, P., Palangie, T., Jouve, M., Garcia-Giralt, E., Fridman, W.H., Magdelenat, H., Falcoff, E. and Billiau, A. Eur. J. Cancer Clin. Oncol. 18 929–935, 1982.
Bocci, V. J. Biol. Resp. Mod. 4: 340–352, 1985.
Bocci, V. Immunol. Today 6: 7–9, 1985.
Scott, G.M. In: Interferon (Ed. I Gresser), Vol. 5, Academic Press, New York, 1983, pp. 85–114.
Billard, C, Sigaux, F., Castaigne, S., Valensi, F., Flandrin, G., Degos, L., Falcoff, E. and Aguet, M. Blood 67: 821–826, 1986.
Wietzerbin, J., Gaudelet, C, Aguet, M. and Falcoff, E. J. Immunol. 136: 2451–2455, 1986.
Bocci, V. In: Interferons (Ed. T. Kishida), Japan Convention Services Inc., Osaka, 1983, pp. 38–44.
Bocci, V., Muscettola, M., Naldini, A., Bianchi, E. and Segre, G. Gen. Pharmac. 17: 93–96, 1986.
Bocci, V. Cancer Drug Delivery 1: 337–351, 1984.
Berek, J.S., Hacker, N.F., Lichtenstein, A., Jung, T., Spina C., Knox, R.M., Brady, J., Greene, T., Ettinger, L.M., Lagasse, L.D., Bonnern, E.M., Spiegel, R.J. and Zighelboim, J. Cancer Res. 45: 4447–4453, 1985.
Langer, R. Pharmac. Ther. 21: 35–51, 1983.
Johnson, R.T. In: Neuroimmunology (Ed. P. Behan and F. Spreafico), Raven Press, New York, 1984, pp. 229–236.
Bullard, D.E., Gillespie, G.Y., Mahaley, M.S. and Bigner, D.D. Seminars Oncol. 13: 94–109, 1986.
Blasberg, R.G. and Groothuis, D.R. Seminars Oncol. 13: 70–82, 1986.
Hasegawa, H., Ushio, Y., Hayakawa, T., Yamada, K. and Mogami, H. J. Neurosurg. 59: 304–310, 1983.
Spigelman, M.K., Zappulla, R.A., Malis, L.I., Holland, J.F., Goldsmith, S.J. and Goldberg, J.D. Neurosurgery 12: 606–612, 1983.
Neuwelt, E.A. and Rapoport, S.I. Fed. Proc. 43: 214–219, 1984.
Spigelman, M.K., Zappulla, R.A., Strauchen, J.A., Feuer, E.J., Johnson, J., Goldsmith, S.J., Malis, L.I. and Holland, J.F. Cancer Res. 46: 1453–1457, 1986.
Omaya, A.K. Cancer Drug Delivery 1: 169–179, 1984.
Koyama, Y. In: Interferons (Ed. T. Kishida), Japan Convention Services Inc., Osaka, 1983, pp. 189–195.
Nagai, M. and Arai, T. Neurosurg. Rev. 7: 55–64, 1984.
Rohatiner, A.Z.S., Prior, P., Burton, A., Balkwill, F. and Lister, T.A. In: Progress in Experimental Tumor Research (Ed. F. Homburger), Vol. 29, S. Karger, Basel, 1985, pp. 197–202.
Parnavelas, J.G., Kelly, W. and Burnstock, G. Nature 316: 724–725, 1985.
Levin, S. and Hahn, T. The Lancet i: 592–594, 1982.
Omata, M., Imazeki, F., Yokosuka, O., Ito, Y., Uchiumi, K., Mori, J. and Okuda, K. Gastroenterology 88: 870–880, 1985.
Ehmann, W.C. and Silber, R. Am. J. Med. 80: 1111–1114, 1986.
Ratain, M.J., Golomb, H.M., Vardiman, J.W., Vokes, E.E., Jacobs, R.H. and Daly, K. Blood 65: 644–648, 1985.
Talpaz, M., Kantarjian, H.M., McCredie, K., Trujillo, J.M., Keating, M.J. and Gutterman, J.U. New England J. Med. 314: 1065–1069, 1986.
Velu, T., Delwiche, F., Gangji, D., Monsieur, R., Flament, J., Stryckmans, P., Wybran, J. and Bellens, R. Oncology 42: suppl. 1, 10–14, 1985.
Foon, K.A., Sherwin, S.A., Abrams, P.G., Longo, D.L., Fer, M.F., Stevenson, H.D., Ochs, J.J., Bottino, G.C., Schoenberger, CS., Zeffren, J., Jaffe, E.S. and Oldham, R.K. NewEngland J. Med. 311: 1148–1152, 1984.
Bunn, P.A., Foon, K.A., Ihde, D.C., Longo,, D.L., Eddy, J., Winkler, CF., Veach, S.R., Zeffren, J., Sherwin, S. and Oldham, R. Ann. Intern. Med. 101: 484–487, 1984.
Volberding, P.A. and Mitsuyasu, R. Seminars Oncol. 12: suppl.5, 2–6, 1985.
Quesada, J.R., Alexanian, R., Hawkins, M., Barlogie, B., Borden, E., Itri, L. and Gutterman, J.U. Blood 67: 275–278, 1986.
Bocci, V. Cancer Drug Delivery 2: 313–318, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Bocci, V. (1988). Pharmacokinetics of Interferons and Practical Implications. In: Revel, M. (eds) Clinical Aspects of Interferons. Developments in Medical Virology, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1737-1_20
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1737-1_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8977-7
Online ISBN: 978-1-4613-1737-1
eBook Packages: Springer Book Archive